138 related articles for article (PubMed ID: 27149377)
1. RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases.
O Santos A; Parrini MC; Camonis J
PLoS One; 2016; 11(5):e0154840. PubMed ID: 27149377
[TBL] [Abstract][Full Text] [Related]
2. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms.
Vigil D; Martin TD; Williams F; Yeh JJ; Campbell SL; Der CJ
J Biol Chem; 2010 Nov; 285(45):34729-40. PubMed ID: 20801877
[TBL] [Abstract][Full Text] [Related]
3. RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells.
D'Aloia A; Berruti G; Costa B; Schiller C; Ambrosini R; Pastori V; Martegani E; Ceriani M
Exp Cell Res; 2018 Jan; 362(2):349-361. PubMed ID: 29208460
[TBL] [Abstract][Full Text] [Related]
4. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
Xu X; Jiang J; Yao L; Ji B
Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
[TBL] [Abstract][Full Text] [Related]
5. Covalent Fragment Screening Identifies Rgl2 RalGEF Cysteine for Targeted Covalent Inhibition of Ral GTPase Activation.
Bum-Erdene K; Ghozayel MK; Xu D; Meroueh SO
ChemMedChem; 2022 Mar; 17(6):e202100750. PubMed ID: 35061330
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 interacts and collaborates with Ral GTPases enhancing cell detachment and motility.
Fernández RM; Ruiz-Miró M; Dolcet X; Aldea M; Garí E
Oncogene; 2011 Apr; 30(16):1936-46. PubMed ID: 21242975
[TBL] [Abstract][Full Text] [Related]
7. Differential involvement of RalA and RalB in colorectal cancer.
Martin TD; Der CJ
Small GTPases; 2012; 3(2):126-30. PubMed ID: 22790202
[TBL] [Abstract][Full Text] [Related]
8. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
[TBL] [Abstract][Full Text] [Related]
9. Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells.
Hamada M; Miki T; Iwai S; Shimizu H; Yura Y
Cancer Chemother Pharmacol; 2011 Sep; 68(3):559-69. PubMed ID: 21107573
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of RalGPS2, a murine guanine nucleotide exchange factor for RalA GTPase.
Ceriani M; Scandiuzzi C; Amigoni L; Tisi R; Berruti G; Martegani E
Exp Cell Res; 2007 Jul; 313(11):2293-307. PubMed ID: 17462626
[TBL] [Abstract][Full Text] [Related]
11. SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers.
Schuld NJ; Hauser AD; Gastonguay AJ; Wilson JM; Lorimer EL; Williams CL
Cell Cycle; 2014; 13(6):941-52. PubMed ID: 24552806
[TBL] [Abstract][Full Text] [Related]
12. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
Falsetti SC; Wang DA; Peng H; Carrico D; Cox AD; Der CJ; Hamilton AD; Sebti SM
Mol Cell Biol; 2007 Nov; 27(22):8003-14. PubMed ID: 17875936
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
14. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.
Tecleab A; Zhang X; Sebti SM
J Biol Chem; 2014 Nov; 289(45):31296-309. PubMed ID: 25210032
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer.
Male H; Patel V; Jacob MA; Borrego-Diaz E; Wang K; Young DA; Wise AL; Huang C; Van Veldhuizen P; O'Brien-Ladner A; Williamson SK; Taylor SA; Tawfik O; Esfandyari T; Farassati F
Lung Cancer; 2012 Aug; 77(2):252-9. PubMed ID: 22498113
[TBL] [Abstract][Full Text] [Related]
16. Parallel Rap1>RalGEF>Ral and Ras signals sculpt the C. elegans nervous system.
Mardick JI; Rasmussen NR; Wightman B; Reiner DJ
Dev Biol; 2021 Sep; 477():37-48. PubMed ID: 33991533
[TBL] [Abstract][Full Text] [Related]
17. The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.
McFarlane C; Kelvin AA; de la Vega M; Govender U; Scott CJ; Burrows JF; Johnston JA
Cancer Res; 2010 Apr; 70(8):3329-39. PubMed ID: 20388806
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of RalGDS by c-Met receptor blocks its interaction with Ras.
Wong R; Feig LA
Biochem Biophys Res Commun; 2016 Nov; 480(3):468-473. PubMed ID: 27773821
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis.
Peschard P; McCarthy A; Leblanc-Dominguez V; Yeo M; Guichard S; Stamp G; Marshall CJ
Curr Biol; 2012 Nov; 22(21):2063-8. PubMed ID: 23063435
[TBL] [Abstract][Full Text] [Related]
20. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines.
Ling YH; Li T; Yuan Z; Haigentz M; Weber TK; Perez-Soler R
Mol Pharmacol; 2007 Aug; 72(2):248-58. PubMed ID: 17456787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
